日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial

Zegocractin治疗伴有全身炎症反应综合征的急性胰腺炎：一项随机、对照、剂量探索的IIb期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103757
Sutton, Robert; Garg, Pramod K; Miller, Joseph; Kumar, S Suresh; Buxbaum, James L; Philip, Mathew; Zhang, Jeffrey; Stauderman, Kenneth; Hebbar, Sudarshan; Wu, Bechien U; Peacock, W Frank; Gardner, Timothy B
胰腺炎
炎症/感染
炎症
发表日期：2026
文献求助 收藏

Structural evidence that RNA contributes to polymorphism of tau amyloid fibrils.

结构证据表明 RNA 参与了 tau 淀粉样蛋白原纤维的多态性。

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2026.115501
Abskharon Romany, Jiang Yi Xiao, Sawaya Michael R, Ge Peng, Zhang Jeffrey, Boyer David R, Dolinsky Joshua L, Pi Justin, Cascio Duilio, Guo Feng, Eisenberg David S
TAU
发表日期：2026
文献求助 收藏

Basivertebral nerve ablation provides comparable early pain relief in patients with psychiatric conditions: A real-world study

一项真实世界研究表明，对于患有精神疾病的患者，椎基底神经消融术可提供与传统手术相当的早期镇痛效果：

期刊:
影响因子:
doi:10.1016/j.inpm.2026.100743
Bellow, Emily; Bae, Jennifer; Zhang, Jeffrey; Bajrami, Sandi; Johnson, Derek; Caldwell, William
发表日期：2026
文献求助 收藏

How short peptides disassemble tau fibrils in Alzheimer's disease.

短肽如何分解阿尔茨海默病中的tau蛋白原纤维

期刊:Nature
影响因子:48.5
doi:10.1038/s41586-025-09244-z
Hou Ke, Ge Peng, Sawaya Michael R, Lutter Liisa, Dolinsky Joshua L, Yang Yuan, Jiang Yi Xiao, Boyer David R, Cheng Xinyi, Pi Justin, Zhang Jeffrey, Lu Jiahui, Abskharon Romany, Yang Shixin, Yu Zhiheng, Feigon Juli, Eisenberg David S
免疫/内分泌
发表日期：2025
文献求助 收藏

Medical foundation large language models for comprehensive text analysis and beyond

用于全面文本分析及其他的医学基金会大型语言模型

期刊:npj Digital Medicine
影响因子:15.1
doi:10.1038/s41746-025-01533-1
Xie, Qianqian; Chen, Qingyu; Chen, Aokun; Peng, Cheng; Hu, Yan; Lin, Fongci; Peng, Xueqing; Huang, Jimin; Zhang, Jeffrey; Keloth, Vipina; Zhou, Xinyu; Qian, Lingfei; He, Huan; Shung, Dennis; Ohno-Machado, Lucila; Wu, Yonghui; Xu, Hua; Bian, Jiang
发表日期：2025
文献求助 收藏

The Development Landscape of Large Language Models for Biomedical Applications

生物医学应用大型语言模型的发展现状

期刊:Annual Review of Biomedical Data Science
影响因子:6
doi:10.1146/annurev-biodatasci-102224-074736
Cao, Zhiyuan; Keloth, Vipina K; Xie, Qianqian; Qian, Lingfei; Liu, Yuntian; Wang, Yan; Shi, Rui; Zhou, Weipeng; Yang, Gui; Zhang, Jeffrey; Peng, Xueqing; Zhen, Ethan; Weng, Ruey-Ling; Chen, Qingyu; Xu, Hua
发表日期：2025
文献求助 收藏

Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites

持续输注特利加压素（BIV201）的安全性和有效性：一项针对失代偿期肝硬化和难治性腹水患者的 2 期试验

期刊:Liver Transplantation
影响因子:3.9
doi:10.1097/LVT.0000000000000623
Bajaj, Jasmohan S; Weinberg, Ethan M; Reddy, K Rajender; Keaveny, Andrew P; Porayko, Michael K; Koch, David; Thuluvath, Paul J; Simonetto, Douglas A; Angeli, Paolo; Janardhan, Sujit V; Orman, Eric S; Zhang, Jeffrey; Clausen, Susan; Dauphinée, Elisa; Palumbo, Joseph M; Markham, Penelope
肝硬化
发表日期：2025
文献求助 收藏

Modic Changes as Biomarkers for Treatment of Chronic Low Back Pain

Modic改变作为慢性腰痛治疗的生物标志物

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13071697
Zhang, Jeffrey; Bellow, Emily; Bae, Jennifer; Johnson, Derek; Bajrami, Sandi; Torpey, Andrew; Caldwell, William
发表日期：2025
文献求助 收藏

An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease

一项探索性分析表明，贝齐特林治疗可降低轻度至中度可能患有阿尔茨海默病患者的生物年龄加速，并改善其临床指标和生物标志物变化。

期刊:Frontiers in Neuroscience
影响因子:3.2
doi:10.3389/fnins.2025.1516746
Reading, Christopher L; Yan, Jiayan; Testa, Marcia A; Simonson, Donald C; Javaid, Hira; Schmunk, Lisa; Martin-Herranz, Daniel E; Brooke, Robert; Gordevicius, Juozas; Zhang, Jeffrey; Yuan, Harvey; Ahlem, Clarence; Wang, Lixia; Markham, Penelope; Osman, Nily; O'Quinn, Stephen; Palumbo, Joseph
阿尔茨海默症
发表日期：2025
文献求助 收藏

Correction: An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease

更正：一项探索性分析表明，贝齐特林治疗可降低轻度至中度可能患有阿尔茨海默病患者的生物年龄加速，并改善其临床指标和生物标志物变化。

期刊:Frontiers in Neuroscience
影响因子:3.2
doi:10.3389/fnins.2025.1758523
Reading, Christopher L; Yan, Jiayan; Testa, Marcia A; Simonson, Donald C; Javaid, Hira; Schmunk, Lisa; Martin-Herranz, Daniel E; Brooke, Robert; Gordevicius, Juozas; Zhang, Jeffrey; Yuan, Harvey; Ahlem, Clarence; Wang, Lixia; Markham, Penelope; Osman, Nily; O'Quinn, Stephen; Palumbo, Joseph
阿尔茨海默症
发表日期：2025
文献求助 收藏